Clinical Trial Update: Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

View source ↗

Summary

A prospective cohort study led by Jinling Hospital in China is evaluating renal cancer monitoring through ctDNA methylomics, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Jinling Hospital, China | Conditions: Carcinoma, Renal Cell Carcinoma | Status: RECRUITING